机构:
Harvard Med Sch, Joslin Diabet Ctr, Boston, MA USA
NYU, Sch Med, Div Endocrinol, New York, NY USAImperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England
Matfin, Glenn
[2
,3
]
机构:
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England
[2] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA USA
[3] NYU, Sch Med, Div Endocrinol, New York, NY USA
Hypercalcaemia is commonly seen in the context of parathyroid dysfunction and malignancy and, when severe, can precipitate life-threatening sequelae. The differential of hypercalcaemia is broad and can be categorized based on parathyroid hormone (PTH) levels. The acute management of severe hypercalcaemia is discussed along with a brief review of therapeutic advances in the field.